Owen, Michael J.
Cardiff University
125 papers on CoChatORCID 0000-0003-4798-0862
Most cited papers
- Verified
De Novo Rates and Selection of Schizophrenia-Associated Copy Number Variants
Rees, E., Moskvina, V., Owen, M. J., O'Donovan, M. C., & Kirov, G. (2011) · Biological Psychiatry
Genomic variations and chromosomal abnormalitiesSchizophrenia research and treatment
Cited by 94
- Verified
A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium
Gur, R. E., Bassett, A. S., McDonald-McGinn, D. M., Bearden, C. E., Chow, E., Emanuel, B. S., Owen, M., Swillen, A., Van den Bree, M., Vermeesch, J., et al. (2017) · Molecular Psychiatry
Genomic variations and chromosomal abnormalitiesSchizophrenia research and treatment
Cited by 93
- Verified
Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome
Monks, S., Niarchou, M., Davies, A. R., Walters, J. T. R., Williams, N., Owen, M. J., van den Bree, M. B. M., & Murphy, K. C. (2014) · Schizophrenia Research
Schizophrenia research and treatmentGenomic variations and chromosomal abnormalities
Cited by 93
- Verified
A cross-sectional and a prospective study of thyroid disorders in lithium-treated patients
Kirov, G., Tredget, J., John, R., Owen, M. J., & Lazarus, J. H. (2005) · Journal of Affective Disorders
Bipolar Disorder and TreatmentThyroid Disorders and Treatments
Cited by 90
- Verified
Effects of Differential Genotyping Error Rate on the Type I Error Probability of Case-Control Studies
Moskvina, V., Craddock, N., Holmans, P., Owen, M. J., & O’Donovan, M. C. (2006) · Human Heredity
Genetic Associations and EpidemiologyGenetic diversity and population structure
Cited by 88
- Verified
Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region With Cortical and Subcortical Morphology and Cognition
Writing Committee for the ENIGMA-CNV Working Group, van der Meer, D., Sønderby, I. E., Kaufmann, T., Walters, G. B., Abdellaoui, A., Ames, D., Amunts, K., Andersson, M., Armstrong, N. J., et al. (2020) · JAMA Psychiatry
Genomic variations and chromosomal abnormalitiesGenetics and Neurodevelopmental Disorders
Cited by 87
- Verified
Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene
Buxbaum, J. D., Georgieva, L., Young, J. J., Plescia, C., Kajiwara, Y., Jiang, Y., Moskvina, V, Norton, N., Peirce, T., Williams, H., et al. (2008) · Molecular Psychiatry
Schizophrenia research and treatmentProtein Tyrosine Phosphatases
Cited by 86
- Verified
Cyfip1 haploinsufficient rats show white matter changes, myelin thinning, abnormal oligodendrocytes and behavioural inflexibility
Silva, A. I., Haddon, J. E., Ahmed Syed, Y., Trent, S., Lin, T.-C. E., Patel, Y., Carter, J., Haan, N., Honey, R. C., Humby, T., et al. (2019) · Nature Communications
Genomic variations and chromosomal abnormalitiesGenetics and Neurodevelopmental Disorders
Cited by 71
- Verified
APOE ε4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome
Deb, S., Braganza, J., Norton, N., Williams, H., Kehoe, P. G., Williams, J., & Owen, M. J. (2000) · British Journal of Psychiatry
Down syndrome and intellectual disability researchAlzheimer's disease research and treatments
Cited by 71
- Verified · note
Charting the landscape of priority problems in psychiatry, part 2: pathogenesis and aetiology
Stephan, K. E., Binder, E. B., Breakspear, M., Dayan, P., Johnstone, E. C., Meyer-Lindenberg, A., Schnyder, U., Wang, X.-J., Bach, D. R., Fletcher, P. C., et al. (2016) · The Lancet Psychiatry
Mental Health and PsychiatryPsychology and Mental Health
Cited by 64
- Verified
Genetic comorbidity between major depression and cardio‐metabolic traits, stratified by age at onset of major depression
Hagenaars, S. P., Coleman, J. R. I., Choi, S. W., Gaspar, H., Adams, M. J., Howard, D. M., Hodgson, K., Traylor, M., Air, T. M., Andlauer, T. F. M., et al. (2020) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and Animals
Cited by 61
- Verified
Investigating the genetic architecture of general and specific psychopathology in adolescence
Jones, H. J., Heron, J., Hammerton, G., Stochl, J., Jones, P. B., Cannon, M., Smith, G. D., Holmans, P., Lewis, G., Linden, D. E. J., et al. (2018) · Translational Psychiatry
Schizophrenia research and treatmentGenetic Associations and Epidemiology
Cited by 59
- Verified
Association between a promoter variant in the monoamine oxidase A gene and schizophrenia
Jönsson, E. G., Norton, N., Forslund, K., Mattila-Evenden, M., Rylander, G., Åsberg, M., Owen, M. J., & Sedvall, G. C. (2003) · Schizophrenia Research
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 57
- Verified
Mutation screening of SCN2A in schizophrenia and identification of a novel loss-of-function mutation
Carroll, L. S., Woolf, R., Ibrahim, Y., Williams, H. J., Dwyer, S., Walters, J., Kirov, G., O’Donovan, M. C., & Owen, M. J. (2016) · Psychiatric Genetics
Schizophrenia research and treatmentIon channel regulation and function
Cited by 54
- Verified
Genome-wide association analysis of copy number variation in recurrent depressive disorder
Rucker, J. J. H., Breen, G., Pinto, D., Pedroso, I., Lewis, C. M., Cohen-Woods, S., Uher, R., Schosser, A., Rivera, M., Aitchison, K. J., et al. (2013) · Molecular Psychiatry
Genomic variations and chromosomal abnormalitiesGenetic Associations and Epidemiology
Cited by 51
- Verified
Misconceptions about gene-environment interactions in psychiatry
Zammit, S., Owen, M. J., & Lewis, G. (2010) · Evidence Based Mental Health
Genetic Associations and EpidemiologyHealth, Environment, Cognitive Aging
Cited by 50
- Verified
Molecular genetic contribution to the developmental course of attention-deficit hyperactivity disorder
Langley, K., Fowler, T. A., Grady, D. L., Moyzis, R. K., Holmans, P. A., van den Bree, M. B. M., Owen, M. J., O’Donovan, M. C., & Thapar, A. (2009) · European Child & Adolescent Psychiatry
Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior
Cited by 47
- Verified
Allelic expression of APOE in human brain: Effects of epsilon status and promoter haplotypes
Bray, N. J., Jehu, L., Moskvina, V., Buxbaum, J. D., Dracheva, S., Haroutunian, V., Williams, J., Buckland, P. R., Owen, M. J., & O'Donovan, M. C. (2004) · Human Molecular Genetics
Alzheimer's disease research and treatmentsGenetic Associations and Epidemiology
Cited by 45
- Verified
Genetic Differences between Five European Populations
Moskvina, V., Smith, M., Ivanov, D., Blackwood, D., StClair, D., Hultman, C., Toncheva, D., Gill, M., Corvin, A., O’Dushlaine, C., et al. (2010) · Human Heredity
Forensic and Genetic ResearchGenetic Associations and Epidemiology
Cited by 38
- Verified
Reciprocal White Matter Changes Associated With Copy Number Variation at 15q11.2 BP1-BP2: A Diffusion Tensor Imaging Study
Silva, A. I., Ulfarsson, M. O., Stefansson, H., Gustafsson, O., Walters, G. B., Linden, D. E. J., Wilkinson, L. S., Drakesmith, M., Owen, M. J., Hall, J., et al. (2019) · Biological Psychiatry
Genomic variations and chromosomal abnormalitiesAdvanced Neuroimaging Techniques and Applications
Cited by 36
- Verified
A Multi-Center Study of ACE and the Risk of Late-Onset Alzheimer's Disease
Belbin, O., Brown, K., Shi, H., Medway, C., Abraham, R., Passmore, P., Mann, D., Smith, A. D., Holmes, C., McGuinness, B., et al. (2011) · Journal of Alzheimer's Disease
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 34
- Verified
Genetic risk for schizophrenia and developmental delay is associated with shape and microstructure of midline white-matter structures
Drakesmith, M., Parker, G. D., Smith, J., Linden, S. C., Rees, E., Williams, N., Owen, M. J., van den Bree, M., Hall, J., Jones, D. K., et al. (2019) · Translational Psychiatry
Genomic variations and chromosomal abnormalitiesSchizophrenia research and treatment
Cited by 31
- Verified
Haploinsufficiency of the schizophrenia and autism risk gene Cyfip1 causes abnormal postnatal hippocampal neurogenesis through microglial and Arp2/3 mediated actin dependent mechanisms
Haan, N., Westacott, L. J., Carter, J., Owen, M. J., Gray, W. P., Hall, J., & Wilkinson, L. S. (2021) · Translational Psychiatry
Neurogenesis and neuroplasticity mechanismsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 29
- Verified
A family-based study of common polygenic variation and risk of schizophrenia
Ruderfer, D. M., Kirov, G., Chambert, K., Moran, J. L., Owen, M. J., O'Donovan, M. C., Sklar, P., & Purcell, S. M. (2011) · Molecular Psychiatry
Genetic Associations and EpidemiologySchizophrenia research and treatment
Cited by 28
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free